Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05238519
PHASE3

Improved Diagnosis of Familial Hypercholesterolemia Across the Northland (ID-FH)

Sponsor: Essentia Health

View on ClinicalTrials.gov

Summary

The overall goal of this study is to promote awareness of Familial Hypercholesterolemia (FH). The investigators aim to enroll patients with suspected FH into the study and will randomize them to receive usual care or motivational interview. Primary study outcomes include knowledge of FH, as well as clinical and patient-reported outcomes. This study aims to promote optimal disease management and improve outcomes of FH patients.

Key Details

Gender

All

Age Range

2 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

300

Start Date

2022-02-15

Completion Date

2026-06

Last Updated

2026-01-16

Healthy Volunteers

Yes

Interventions

BEHAVIORAL

Motivational interview (MI)

The MI intervention is adapted from the CHEERS study intervention (M Health Fairview) found to be effective in promoting lipid screening in patients at increased risk for FH. Within one month of completion of the baseline survey, a study coordinator, who received training in motivational interview integrity, will conduct a 20-40-minute (depending on participant needs) telephone or virtual (zoom) interview with participants randomized to this arm. Participants will be assessed on their readiness to get their cholesterol checked and discuss with family members the risk of FH.

Locations (2)

Aspirus St. Luke's Hospital

Duluth, Minnesota, United States

Essentia Health

Duluth, Minnesota, United States